Peter J. Bye

Jefferies & Company analysts Peter J. Bye, Joshua Jennings and Anthony Petrone maintained their Buy rating for shares of St. Jude Medical, Inc. (NYSE: STJ), with a price target of $49 per share. The analysts said that the Department of Justice had given St. Jude Medical, Inc. a "civil...